Initiating treatment with empagliflozin: algorithms, notes and talking points

15 minutes to Delve
Richard French, Brendan Duck
21 May 2021
Image of a flowchart

When clinically indicated, empagliflozin can be started in adult patients with type 2 diabetes using the steps shown in this resource. Always maintain metformin treatment if tolerated.

Talking points, relevant for all patients starting empagliflozin, are provided along with two algorithms and accompanying prescribing notes. Which algorithm you follow will depend on your patient’s level of hypoglycaemia risk.

Click here to download the algorithms, notes and talking points.

Log in, CAPTURE your learning and add to your professional development records.


Medsafe, New Zealand Medicines and Medical Devices Safety Authority. Jardiance (empagliflozin) data sheet. Accessed April 2021.

New Zealand Society for the Study of Diabetes (NZSSD). Type 2 Diabetes Management Guidance. Accessed April 2021.

PHARMAC. Decision to fund two new medicines for type 2 diabetes - Amended with Q&A. January 2021. Accessed April 2021.

Zinman B, Wanner C, Lachin J et al. Empagliflozin, cardiovascular outcomes and mortality in type 2 diabetes. NEJM. 2015;373(22):2117-28